Crossmark Global Holdings Inc. lifted its stake in Houlihan Lokey, Inc. (NYSE:HLI – Free Report) by 25.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,688 shares of the financial services provider’s stock after purchasing an additional 944 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Houlihan Lokey were worth $741,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently bought and sold shares of the company. Millennium Management LLC raised its holdings in Houlihan Lokey by 24,074.0% in the second quarter. Millennium Management LLC now owns 501,610 shares of the financial services provider’s stock worth $67,647,000 after buying an additional 499,535 shares during the last quarter. Fiera Capital Corp raised its holdings in Houlihan Lokey by 666.8% in the 3rd quarter. Fiera Capital Corp now owns 283,702 shares of the financial services provider’s stock worth $44,831,000 after acquiring an additional 246,705 shares during the last quarter. PineStone Asset Management Inc. bought a new position in Houlihan Lokey in the 2nd quarter valued at approximately $10,141,000. Earnest Partners LLC lifted its position in Houlihan Lokey by 1.9% in the 2nd quarter. Earnest Partners LLC now owns 3,273,818 shares of the financial services provider’s stock valued at $441,507,000 after acquiring an additional 62,314 shares in the last quarter. Finally, New York State Common Retirement Fund increased its holdings in shares of Houlihan Lokey by 42.0% in the 3rd quarter. New York State Common Retirement Fund now owns 183,976 shares of the financial services provider’s stock worth $29,072,000 after purchasing an additional 54,386 shares in the last quarter. Institutional investors own 78.07% of the company’s stock.
Houlihan Lokey Trading Down 0.0 %
Shares of HLI stock opened at $184.05 on Friday. The company has a 50 day simple moving average of $166.88 and a two-hundred day simple moving average of $149.50. The stock has a market cap of $12.80 billion, a P/E ratio of 37.64 and a beta of 0.65. Houlihan Lokey, Inc. has a 12 month low of $102.29 and a 12 month high of $190.66.
Houlihan Lokey Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, December 15th. Investors of record on Monday, December 2nd will be paid a dividend of $0.57 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.24%. Houlihan Lokey’s dividend payout ratio (DPR) is presently 46.63%.
Insider Activity at Houlihan Lokey
In related news, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total value of $30,498.00. Following the completion of the transaction, the director now owns 7,001 shares of the company’s stock, valued at approximately $1,067,582.49. This represents a 2.78 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, General Counsel Christopher M. Crain sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total value of $155,290.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,600 shares of company stock worth $249,860. 23.68% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on the company. Morgan Stanley upped their price target on Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a report on Monday, September 23rd. StockNews.com upgraded shares of Houlihan Lokey from a “hold” rating to a “buy” rating in a research note on Tuesday. Keefe, Bruyette & Woods restated a “market perform” rating and set a $154.00 price objective (up previously from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. JPMorgan Chase & Co. cut their target price on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a research report on Wednesday, July 31st. Finally, UBS Group increased their price target on Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $157.00.
Read Our Latest Research Report on Houlihan Lokey
Houlihan Lokey Company Profile
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
See Also
- Five stocks we like better than Houlihan Lokey
- Best Stocks Under $10.00
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Top-Performing Non-Leveraged ETFs This Year
- What is the Shanghai Stock Exchange Composite Index?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI – Free Report).
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.